Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

7.69
+0.17502.33%
Volume:280.65K
Turnover:2.14M
Market Cap:502.49M
PE:57.49
High:7.74
Open:7.46
Low:7.46
Close:7.51
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:0.51
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:0.89
PE(LYR):-6.74

Loading ...

Arvinas Holding Company (ARVN) Gets a Buy from Barclays

TIPRANKS
·
Aug 05

Wells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027

TIPRANKS
·
Aug 05

Wedbush Adjusts Price Target on Arvinas to $12 From $11, Maintains Neutral Rating

MT Newswires Live
·
Aug 04

Arvinas Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Arvinas Q2 Operating Income USD 164.1 Million

Reuters
·
Aug 04

Arvinas Swings to FY26 Q2 Net Income of $169.4 Million; Revenue More than Doubled to $249.7 Million

Reuters
·
Aug 04

Arvinas Q2 EPS $2.58 Beats $(0.44) Estimate, Sales $249.700M Beat $32.542M Estimate

Benzinga Earnings
·
Aug 04

Arvinas Q2 Operating Expenses USD 85.6 Million

THOMSON REUTERS
·
Aug 04

Arvinas Q2 Net Income USD 169.4 Million

THOMSON REUTERS
·
Aug 04

Arvinas - Cash Position Expected to Fund Operations into Second Half of 2028

THOMSON REUTERS
·
Aug 04

Arvinas Shareholders Elect Two Directors at Annual Meeting

Reuters
·
Jun 26

Arvinas CMO Noah Berkowitz to depart July 3, company starts search for successor

Reuters
·
Jun 23

Rigel Pharmaceuticals pays $70 million upfront for global rights to Arvinas-Pfizer breast cancer drug VEPPANU

Reuters
·
Jun 18

Rigel Deal for VEPPANU Cleared, Arvinas Receives Payment

TIPRANKS
·
Jun 17

BRIEF-Arvinas - Pfizer, And Rigel Receive Hart-Scott-Rodino Clearance For License Agreement On June 11, 2026

Reuters
·
Jun 17

Arvinas - Pfizer, and Rigel Receive Hsr Clearance for License Agreement on June 11, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 17

Arvinas - Co and Pfizer Eligible for up to $320 Mln in Milestone Payments and Tiered Royalties - SEC Filing

THOMSON REUTERS
·
Jun 17

Rigel closes VEPPANU license deal, makes USD 70 million upfront payment

Reuters
·
Jun 17

Arvinas joins MJFF-backed PPMI study to support development of LRRK2 degrader ARV-102 for Parkinson’s

Reuters
·
Jun 04

Arvinas Joins the Michael J. Fox Foundation’s Lite and Ppmi Programs to Advance New Therapies Targeting Lrrk2 for Parkinson’s Disease

THOMSON REUTERS
·
Jun 04